Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls
Joint Authors
Meysamie, Alipasha
Maleki, Akram
Larijani, Bagher
Nikmanesh, Bahram
Nikbin, Behrouz
Roohi, Azam
Tabrizi, Mina
Shafiey, Novin
Asgarian-Omran, Hossein
Bajouri, Arezou
Qorbani, Mostafa
Ataie-Jafari, Asal
Abbasi, Farzaneh
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-06-04
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Type 1 diabetes is recognized as an autoimmune inflammatory disease and low grade inflammation is also observed in type 2 diabetic patients.
Interleukin 17 (IL-17) is a new player in inflammation.
Th17 cells, as the main source of IL-17, require transforming growth factor β (TGF-β) and interleukin 23 (IL-23).
The aim of this study was to investigate serum IL-17, IL-23 and TGF-β levels in diabetic patients and controls.
In this case-control study, serum levels of IL-17, IL-23, and TGF-β were measured in 24 type 1 diabetic patients and 30 healthy controls using the ELISA method.
Simultaneously, the same methodology was used to compare serum concentration of these three cytokines in 38 type 2 diabetic patients and 40 healthy controls.
There was no significant difference between serum levels of IL-17 and IL-23 cytokines between cases and controls.
However, TGF-β was significantly lower in type 1 diabetic patients (P<0.001).
Serum IL-17 and IL-23 levels demonstrate no association with type 1 and type 2 diabetes, but, in line with previous studies, TGF-β levels were lower in type 1 diabetic patients.
American Psychological Association (APA)
Roohi, Azam& Tabrizi, Mina& Abbasi, Farzaneh& Ataie-Jafari, Asal& Nikbin, Behrouz& Larijani, Bagher…[et al.]. 2014. Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls. BioMed Research International،Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-493121
Modern Language Association (MLA)
Roohi, Azam…[et al.]. Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls. BioMed Research International No. 2014 (2014), pp.1-7.
https://search.emarefa.net/detail/BIM-493121
American Medical Association (AMA)
Roohi, Azam& Tabrizi, Mina& Abbasi, Farzaneh& Ataie-Jafari, Asal& Nikbin, Behrouz& Larijani, Bagher…[et al.]. Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-493121
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-493121